SMEInst-05-2016-2017
SMEInst-05-2016-2017
107 projects · €112,881,738 total EU contribution (project-level) · 108 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€112,881,738
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (15)
- Spain (13)
- France (11)
- Italy (10)
- SE (10)
- IL (8)
- Germany (7)
- Netherlands (6)
- PT (6)
- DK (4)
- IE (3)
- PL (3)
- AT (2)
- IS (2)
- NO (2)
- BE (1)
- CZ (1)
- EE (1)
- HU (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AENITIS TECHNOLOGIES2 projects · FR
- EBERS2 projects · ES
- THE ZEBRAFISH LAB2 projects · ES
- METAFORA BIOSYSTEMS2 projects · FR
- SYMCEL2 projects · SE
- 2CUREX A/S1 projects · DK
- 2CUREX GMBH1 projects · DE
- AMADIX1 projects · ES
- AEQUOR1 projects · UK
- AGLARIS1 projects · UK
- ALLTOX1 projects · IT
- ALTRATECH LIMITED1 projects · IE
Projects
Page 7 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Chemically synthesised novel compounds for the stabilisation of biologics ExtremoChem · 744677 | H2020 | €50,000 | €71,429 | Details |
A novel class of antibiotics for treatment of infected atopic dermatitis: an innovative solution for a significant unmet medical need ATx201 · 736508 | H2020 | €50,000 | €71,429 | Details |
Detecting serious diseases due to abnormal cellular energetics METAdiag · 806038 | H2020 | €3,202,530 | €3,202,530 | Details |
Spark-Tube Biobanking System (STBS) SPARK-TUBE · 735709 | H2020 | €50,000 | €71,429 | Details |
Drug CandIdates ScreenINg DeCISIoN · 726513 | H2020 | €3,228,570 | €193,750 | Details |
DualDur: A Disruptive Diagnostic Technology that Enables for the First Time an Early and Accurate Diagnosis of the tick-borne Lyme Disease. DualDur · 805609 | H2020 | €3,507,750 | €3,507,750 | Details |
Commercial feasibility of the Novio-PlainGel: a novel synthetic, reversible thermosensitive, biomimetic hydrogel for organoid-based precision medicine OPTIMIsE · 729199 | H2020 | €50,000 | €71,429 | Details |
A point of care device to provide real-time blood analysis for chronic diseases. spinitCompanion · 744341 | H2020 | €50,000 | €71,429 | Details |
MYA, the innovative diagnostics platform for the full mapping of personal allergies MYA · 728239 | H2020 | €50,000 | €71,429 | Details |
An innovative, non-invasive and de-risked system to enable the transdermal delivery of fragile therapeutic compounds for a better management of painful diseases NANO-GROWTH · 761509 | H2020 | €50,000 | €71,429 | Details |